NYSE:MTX
NYSE:MTXChemicals

Minerals Technologies (MTX) Valuation Check After Asia Packaging Expansion And New Plant Plans

Minerals Technologies (MTX) has put its paper and packaging business in Asia firmly in focus, with three new satellite plants starting in 2025, a capacity doubling in India, and another plant planned in China for early 2026. See our latest analysis for Minerals Technologies. The expansion news comes as Minerals Technologies' share price has climbed 10.9% over the past month and 10.4% over the past quarter. However, the 1 year total shareholder return of an 11.2% decline and the low single...
NYSE:BXP
NYSE:BXPOffice REITs

The Bull Case For BXP (BXP) Could Change Following Starr’s 20-Year 343 Madison HQ Lease - Learn Why

BXP recently announced that Starr, a global investment and insurance organization, signed a 20-year lease for approximately 275,000 square feet, about 30% of the space, at 343 Madison Avenue, a 930,000 square foot, fully electric tower in Midtown Manhattan that BXP expects to deliver in late 2029. The long-term, headquarters lease with an investment-grade tenant at 343 Madison Avenue highlights early pre-leasing momentum and helps underpin BXP's large, sustainability-focused development,...
ENXTPA:GET
ENXTPA:GETInfrastructure

Assessing Getlink (ENXTPA:GET) Valuation After Mixed 2025 Traffic Trends

Getlink (ENXTPA:GET) has put fresh operating data on the table, with December and full year 2025 traffic figures showing softer freight volumes alongside slightly higher annual passenger vehicle numbers for its LeShuttle services. See our latest analysis for Getlink. At a share price of €16.18, Getlink has seen a 5.27% 1 month share price return and a 3.65% 3 month share price return. The 1 year total shareholder return of 8.99% and 5 year total shareholder return of 38.83% suggest momentum...
NasdaqCM:IMNM
NasdaqCM:IMNMBiotechs

Immunome (IMNM) Is Up 6.4% After Strong Phase 3 Varegacestat Data and 2026 FDA Plan - What's Changed

In December, Immunome, Inc. reported positive topline results from its Phase 3 RINGSIDE trial, showing Varegacestat improved progression-free survival versus placebo and plans to seek FDA approval in the second quarter of 2026. The data, including a marked reduction in the risk of death or disease progression and a high rate of tumor shrinkage, positions Varegacestat as a potentially important addition to Immunome’s oncology pipeline. Next, we’ll examine how Varegacestat’s strong Phase 3...
NasdaqGS:FTRE
NasdaqGS:FTRELife Sciences

Assessing Fortrea Holdings (FTRE) Valuation After Evercore ISI Upgrade And Recent Share Price Rebound

Fortrea Holdings (FTRE) saw its shares climb 4.8% after Evercore ISI upgraded the stock, citing stronger than expected revenue and profit margins, progress on debt reduction, and a quickening biopharma cycle. See our latest analysis for Fortrea Holdings. Even after the upgrade driven jump, Fortrea’s recent trading has been choppy. The 1 day share price return of 3.38% contrasts with 7 day and 30 day share price returns of 5.12% and 6.99% declines. A 90 day share price return of 58.35% hints...
NYSE:POST
NYSE:POSTFood

Assessing Post Holdings (POST) Valuation After Mixed Recent Returns And Analyst Upside Estimates

What the recent return profile says about Post Holdings stock Post Holdings (POST) shares have tracked a mixed path recently, with a 1 day gain of about 1.3%, modest movement over the past week, and declines over the month and past 3 months. Over longer periods, the picture shifts, with negative total return over the past year but positive outcomes over 3 and 5 years. This can matter if you are thinking about holding the stock through different market cycles. Alongside that performance...
NasdaqGS:IDYA
NasdaqGS:IDYABiotechs

Assessing IDEAYA Biosciences (IDYA) Valuation After Bullish Analyst Reports And Big Pharma Partnerships

IDEAYA Biosciences (IDYA) is back in focus after a cluster of upbeat analyst reports highlighted its precision oncology pipeline and its partnerships with GlaxoSmithKline, Pfizer, and Gilead, drawing fresh attention to the stock. See our latest analysis for IDEAYA Biosciences. After a strong run that leaves the 1 year total shareholder return at 61.59% and the 3 year total shareholder return just over double, recent 7 day and 1 day share price weakness sits against a 90 day share price return...
NYSE:IIPR
NYSE:IIPRIndustrial REITs

How Investors Are Reacting To Innovative Industrial Properties (IIPR) Easing Frictions From Cannabis DUI Law Rethink

Recently published government-funded research has challenged the scientific basis of existing US cannabis DUI laws, arguing they often penalize drivers without clear evidence of impairment and may be leading to wrongful incarceration. This push to modernize THC intoxication standards could ease regulatory frictions for the legal cannabis ecosystem, indirectly supporting ancillary players such as cannabis-focused landlord Innovative Industrial Properties. We’ll now consider how fresh scrutiny...
NYSE:PB
NYSE:PBBanks

Assessing Prosperity Bancshares (PB) Valuation After Mixed Short And Long Term Shareholder Returns

Prosperity Bancshares (PB) has been drawing attention after recent share price moves, with the stock closing at US$72.39 and showing mixed returns over the past year and the past 3 months. See our latest analysis for Prosperity Bancshares. The recent pullback in the 1-day share price return of 1% comes after a stronger 90-day share price return of 13.09%. At the same time, the 1-year total shareholder return shows a decline of 5.08%, indicating that longer term results have been more muted...
NasdaqGM:APGE
NasdaqGM:APGEBiotechs

A Look At Apogee Therapeutics (APGE) Valuation After Positive Asthma Trial Data And 2026 Pipeline Milestones

Asthma data and 2026 pipeline milestones come into focus Apogee Therapeutics (APGE) attracted fresh attention after reporting positive interim Phase 1b data for zumilokibart in mild to moderate asthma, alongside outlining key 2026 milestones across atopic dermatitis and other inflammatory indications. See our latest analysis for Apogee Therapeutics. Against this backdrop, Apogee’s recent asthma update and 2026 pipeline timeline arrive after a strong 90 day share price return of 41.85% and a 1...
NasdaqCM:UFPT
NasdaqCM:UFPTMedical Equipment

Assessing UFP Technologies (UFPT) Valuation After Recent Double Digit Short Term Share Price Gains

UFP Technologies (UFPT) has drawn attention after recent share price moves, with the stock showing double digit returns over the past month and over the past 3 months, in contrast with a slightly negative 1 year total return. See our latest analysis for UFP Technologies. At a share price of $260.52, UFP Technologies has seen short term momentum build, with double digit 30 day and 90 day share price returns. This is occurring even though the 1 year total shareholder return is slightly...
NasdaqGS:MRCY
NasdaqGS:MRCYAerospace & Defense

Do Mercury Systems’ (MRCY) New Space Contracts Clarify Its Long-Cycle Defense Investment Narrative?

Mercury Systems, Inc. recently announced contract awards totaling more than US$60 million for two critical U.S. space and strategic weapons programs, including a development contract extension on a large strategic weapons effort running through 2031 and a new award to supply radiation-tolerant subsystems for a national security space mission. The wins highlight growing customer adoption of Mercury’s radiation-hardened and radiation-tolerant processing technologies, including subsystems built...
NYSE:CNM
NYSE:CNMTrade Distributors

Is Core & Main’s Supply Chain-Fueled Earnings Beat Reshaping The Investment Case For CNM?

In the recent quarter, Core & Main reported revenue growth of 1.2% year on year and delivered adjusted operating income above analyst expectations, signaling resilient demand across its water infrastructure distribution business. This earnings performance highlights how Core & Main’s focus on supply chain and inventory management is becoming a central driver of its operational strength within industrial distribution. With this earnings beat underscoring operational execution, we’ll now...
NYSE:KBH
NYSE:KBHConsumer Durables

How KB Home's New SoCal Energy-Efficient Communities Could Shape KB Home (KBH) Investors’ Outlook

Earlier this month, KB Home announced the grand openings of its Meridian and Solstice communities in Ontario and the Somerset community in Victorville, expanding its presence in Southern California with ENERGY STAR®-designed, highly customizable homes and family-focused amenities. These launches highlight KB Home’s emphasis on personalized design, energy and water efficiency, and master-planned community living, reinforcing its customer-satisfaction positioning as a #1 national homebuilder...
NYSE:KGS
NYSE:KGSEnergy Services

A Look At Kodiak Gas Services (KGS) Valuation After Analyst Upgrades And Confidence In Future Demand

Kodiak Gas Services (KGS) is back in focus after a cluster of analyst upgrades and fresh research pointing to firm demand for its gas compression services, tight equipment supply, and solid execution. See our latest analysis for Kodiak Gas Services. At a share price of $37.73, Kodiak Gas Services has posted a 7.04% 90 day share price return, while its 1 year total shareholder return of 16.31% decline shows that recent momentum has picked up after a weaker year, likely helped by the analyst...
NYSE:MOG.A
NYSE:MOG.AAerospace & Defense

Are Cautious Earnings Forecasts Recasting Moog’s (MOG.A) Management Messaging From Growth Story To Validation Test?

Moog Inc. recently presented at CJS Securities’ 26th Annual “New Ideas for the New Year” Investor Conference on January 14, 2026, featuring Executive VP & CFO Jennifer Walter and President, CEO & Director Patrick J. Roche outlining the company’s current positioning and outlook. At the same time, analysts’ more cautious earnings forecasts ahead of Moog’s upcoming December 2025-quarter results have introduced fresh uncertainty around a company that had previously been consistently ahead of...
TSX:BLX
TSX:BLXRenewable Energy

How Investors May Respond To Boralex (TSX:BLX) Launching Its First Large-Scale Canadian Battery Storage Asset

Boralex Inc., in partnership with Walpole Island First Nation, has commissioned the Sanjgon Battery Energy Storage facility in Lakeshore, Ontario, its first operational North American storage asset with 80 MW / 320 MWh of capacity and a Community Benefit Agreement supporting local initiatives. This project advances Boralex’s 2030 strategy, reinforces its position as Canada’s largest battery storage operator, and highlights a model of long-term collaboration with Indigenous and municipal...
NasdaqGS:ETOR
NasdaqGS:ETORCapital Markets

A Look At eToro Group (ETOR) Valuation After Recent Share Price Weakness

Event context and immediate market snapshot eToro Group (ETOR) is drawing fresh attention after recent trading performance, with the share price closing at $31.33 and short term returns showing a mix of small daily moves and weaker month and past 3 months performance. For investors watching entry points, this recent stretch includes a 1 day return of 0.19%, along with negative moves of 0.92% over the past week, 13.48% over the past month, and 20.80% over the past 3 months. See our latest...
TSXV:LMN
TSXV:LMNSoftware

Assessing Lumine Group (TSXV:LMN) Valuation After Mark Leonard’s Long-Term Endorsement

Recent comments from Constellation Software founder Mark Leonard, who said he wants his grandchildren to hold Lumine Group (TSXV:LMN) for life, have put fresh attention on the company and its telecom and media software focus. See our latest analysis for Lumine Group. Despite the renewed attention from Mark Leonard’s comments, Lumine Group’s share price has come under pressure, with a 30 day share price return of 10.27% and a 90 day share price return of 30.95%. However, the 1 year total...
NasdaqGS:HUBG
NasdaqGS:HUBGLogistics

Analyst Upgrades and Rail Merger Hopes Might Change The Case For Investing In Hub Group (HUBG)

In recent days, Hub Group has drawn renewed attention after several major research firms upgraded their views or reaffirmed positive ratings, citing expectations of improving intermodal volumes, resilient cash generation, and benefits from ongoing tuck-in acquisitions across brokerage, last‑mile, and dedicated services. A key twist is Evercore ISI’s view that Hub Group could be a prime beneficiary of the proposed Union Pacific–Norfolk Southern merger, given its scale as an asset-based...